The next wave of GLP-1 drugs are coming—and they’re stronger than Wegovy and Zepbound (opens in new tab)

The upcoming drugs CagriSema and retatrutide target multiple gut hormones and could cause twice as much weight loss than current treatments. But experts wonder how much is too much